XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning of the period (in shares) at Mar. 31, 2016   173,106   10,697    
Beginning of the period at Mar. 31, 2016 $ 759,948 $ 30,148 $ 6,616 $ (128,407) $ 963,576 $ (111,985)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income $ 166,004       166,451 (447)
Purchase of registered shares (in shares) 3,300     3,321    
Purchases of registered shares $ (63,764)     $ (63,764)    
Tax effects from share-based awards (1,463)   (1,463)      
Sales of shares upon exercise of stock options and purchase rights 20,355   6,435 $ 13,920    
Sales of shares upon exercise of options and purchase rights (in shares)       (1,524)    
Issuance of shares upon vesting of restricted stock units (13,054)   (21,714) $ 10,909 (2,249)  
Issuance of shares upon vesting of restricted stock units (in shares)       (1,196)    
Share-based compensation 26,462   26,462      
Cash dividends (93,093)       (93,093)  
End of the period (in shares) at Dec. 31, 2016   173,106   11,298    
End of the period at Dec. 31, 2016 801,395 $ 30,148 16,336 $ (167,342) 1,034,685 (112,432)
Increase (Decrease) in Shareholders' Equity            
Cumulative effect of adoption of new accounting standard (Note 1) 57,205   3,293   53,912  
Beginning of the period (in shares) at Mar. 31, 2017   173,106   10,727    
Beginning of the period at Mar. 31, 2017 856,111 $ 30,148 26,596 $ (174,037) 1,074,110 (100,706)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income $ 179,677       174,138 5,539
Purchase of registered shares (in shares) 600     581    
Purchases of registered shares $ (20,408)     $ (20,408)    
Sales of shares upon exercise of stock options and purchase rights 30,947   15,958 $ 14,989    
Sales of shares upon exercise of options and purchase rights (in shares)       (1,126)    
Issuance of shares upon vesting of restricted stock units (25,505)   (40,402) $ 14,897 0  
Issuance of shares upon vesting of restricted stock units (in shares)       (1,283)    
Share-based compensation 33,457   33,457      
Cash dividends (104,248)       (104,248)  
End of the period (in shares) at Dec. 31, 2017   173,106   8,899    
End of the period at Dec. 31, 2017 $ 1,007,236 $ 30,148 $ 38,902 $ (164,559) $ 1,197,912 $ (95,167)